(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are SmileDirectClub, Aurora Cannabis, and KB Financial Group.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | SmileDirectClub (SDC) | 0.72 | 5% | 2023-07-19 07:30:30 |
| 2 | Aurora Cannabis (ACB) | 0.55 | 4.32% | 2023-07-19 04:46:56 |
| 3 | KB Financial Group (KB) | 39.91 | 2.97% | 2023-07-19 04:41:40 |
| 4 | Shinhan Financial Group (SHG) | 27.71 | 2.97% | 2023-07-19 04:44:29 |
| 5 | Nautilus (NLS) | 1.08 | 1.89% | 2023-07-19 04:42:49 |
| 6 | Nio (NIO) | 10.56 | 1.34% | 2023-07-19 04:42:44 |
| 7 | Deutsche Bank (DB) | 11.19 | 1.08% | 2023-07-19 07:33:01 |
| 8 | NeuroMetrix (NURO) | 0.95 | 1.05% | 2023-07-19 04:35:57 |
| 9 | DouYu (DOYU) | 1.05 | 0.96% | 2023-07-19 07:13:58 |
| 10 | Tilray (TLRY) | 1.68 | 0.9% | 2023-07-19 07:30:47 |
The three biggest losers today are Advanced Semiconductor Engineering, Banco Bradesco, and Canopy Growth.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Advanced Semiconductor Engineering (ASX) | 8.03 | -1.95% | 2023-07-19 04:37:47 |
| 2 | Banco Bradesco (BBDO) | 2.96 | -1.33% | 2023-07-19 04:38:10 |
| 3 | Canopy Growth (CGC) | 0.38 | -1.31% | 2023-07-19 07:21:39 |
| 4 | Manulife Financial (MFC) | 19.04 | -1.24% | 2023-07-19 04:42:19 |
| 5 | HSBC (HSBC) | 40.57 | -0.95% | 2023-07-19 07:18:55 |
| 6 | Xenetic Biosciences (XBIO) | 3.75 | -0.93% | 2023-07-19 07:31:09 |
| 7 | Prudential Public Limited Company (PUK) | 27.99 | -0.82% | 2023-07-19 04:43:54 |
| 8 | Banco Santander (SAN) | 3.90 | -0.76% | 2023-07-19 04:44:19 |
| 9 | Gevo (GEVO) | 1.75 | -0.6% | 2023-07-19 07:09:52 |
| 10 | Horizon Therapeutics (HZNP) | 103.55 | -0.43% | 2023-07-19 04:10:10 |
Premarket Winners today
1. SmileDirectClub (SDC) – Premarket: 5%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub falling 8.33% to $0.68 on Wednesday while NASDAQ jumped 0.76% to $14,353.64.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.
More news about SmileDirectClub.
2. Aurora Cannabis (ACB) – Premarket: 4.32%
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.
NYSE ended the session with Aurora Cannabis sliding 0.87% to $0.53 on Wednesday, after five sequential sessions in a row of losses. NYSE rose 0.64% to $16,156.51, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-5.63.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aurora Cannabis’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for Aurora Cannabis is 2986790 which is 13.44% below its average volume of 3450560.
More news about Aurora Cannabis.
3. KB Financial Group (KB) – Premarket: 2.97%
KB Financial Group Inc. provides a range of banking and related financial services to consumers and corporations in South Korea and internationally. The company operates through seven segments: Retail Banking, Corporate Banking, Other Banking, Credit Card, Securities, Life Insurance, and Non-Life Insurance. It offers loans, deposit products, and other related financial products and services to large, small, and medium-sized enterprises, as well as individuals and households; investment banking, and brokerage and supporting services; life insurance products; non-life insurance products, including automobile, fire and allied lines, and marine insurance; bancassurance services; and credit sale, cash service, card loan, and other supporting services. The company also engages in securities and derivatives trading, funding, and other supporting activities. In addition, it offers foreign exchange transaction; financial investment; credit card and installment financing; financial leasing; real estate trust management; capital investment; collection of receivables or credit investigation; software advisory, development, and supply; investment advisory; claim; management; savings banking; information and communication; and general advisory services. The company was founded in 1963 and is headquartered in Seoul, South Korea.
NYSE ended the session with KB Financial Group rising 0.06% to $38.76 on Wednesday, after five successive sessions in a row of gains. NYSE rose 0.64% to $16,156.51, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, KB Financial Group has a trailing twelve months EPS of $8.47.
PE Ratio
KB Financial Group has a trailing twelve months price to earnings ratio of 4.58. Meaning, the purchaser of the share is investing $4.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.05%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 28, 2023, the estimated forward annual dividend rate is 1.85 and the estimated forward annual dividend yield is 4.82%.
Volatility
KB Financial Group’s last week, last month’s, and last quarter’s current intraday variation average was 0.89%, 0.08%, and 1.20%.
KB Financial Group’s highest amplitude of average volatility was 0.89% (last week), 1.50% (last month), and 1.20% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 13.48T for the twelve trailing months.
More news about KB Financial Group.
4. Shinhan Financial Group (SHG) – Premarket: 2.97%
Shinhan Financial Group Co., Ltd. provides financial products and services in South Korea and internationally. The company operates through six segments: Banking, Credit Card, Securities, Life Insurance, Credit, and Others. It offers retail banking services, including demand, savings, and fixed deposit-taking; checking accounts; mortgage and home equity, and retail lending; electronic banking and automatic teller machines (ATM); and bill paying, payroll and check-cashing, currency exchange, and wire fund transfer services. The company also provides corporate banking services, such as investment banking, real estate financing, overseas real estate and development project financing, infrastructure and structured financing, equity/venture investments, mergers and acquisitions consulting; securitization and derivatives services comprising securities and derivative products, and foreign exchange trading; and working capital loans and facilities loans. In addition, it is involved in treasury and investment activities in international capital markets consisting of foreign currency-denominated securities trading, foreign exchange trading and services, trade-related financial services, international factoring services, and foreign banking operations. Further, the company offers real estate trust, investment advisory, venture capital, non-life insurance, trust account management, securities brokerage, and asset management services, as well as leasing and equipment financing, savings banking, loan collection and credit reporting, collective investment administration, private equity investment, and financial system development services. Shinhan Financial Group Co., Ltd. was founded in 1982 and is headquartered in Seoul, South Korea.
NYSE ended the session with Shinhan Financial Group dropping 0.66% to $26.91 on Wednesday, following the last session’s downward trend. NYSE rose 0.64% to $16,156.51, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Shinhan Financial Group has a trailing twelve months EPS of $6.67.
PE Ratio
Shinhan Financial Group has a trailing twelve months price to earnings ratio of 4.03. Meaning, the purchaser of the share is investing $4.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Dec 28, 2022, the estimated forward annual dividend rate is 1.25 and the estimated forward annual dividend yield is 4.69%.
Volume
Today’s last reported volume for Shinhan Financial Group is 98730 which is 17.02% below its average volume of 118988.
More news about Shinhan Financial Group.
5. Nautilus (NLS) – Premarket: 1.89%
Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates through two segments, Direct and Retail. It offers cardio products, exercise bikes, treadmills, ellipticals, home gyms, dumbbells, kettlebells, and barbells primarily under the Nautilus, Bowflex, and Schwinn brands, as well as digital fitness platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online-only retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.
NYSE ended the session with Nautilus rising 0.95% to $1.06 on Wednesday while NYSE rose 0.64% to $16,156.51.
Earnings Per Share
As for profitability, Nautilus has a trailing twelve months EPS of $-3.28.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -95.4%.
Volume
Today’s last reported volume for Nautilus is 94180 which is 40.24% below its average volume of 157606.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nautilus’s stock is considered to be overbought (>=80).
Moving Average
Nautilus’s worth is way under its 50-day moving average of $1.24 and way under its 200-day moving average of $1.51.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 77.1% and 26.8%, respectively.
More news about Nautilus.
6. Nio (NIO) – Premarket: 1.34%
NIO Inc. designs, develops, manufactures, and sells smart electric vehicles in China. It offers five and six-seater electric SUVs, as well as smart electric sedans. The company also offers power solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Charger and Destination Charger; Power Mobile, a mobile charging service through charging vans; Power Map, an application that provides access to a network of public chargers and their real-time information; and One Click for Power valet service. In addition, it provides repair, maintenance, and bodywork services through its NIO service centers and authorized third-party service centers; statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance; courtesy vehicle services; roadside assistance; data packages; and auto financing and financial leasing services. Further, the company involved in the provision of energy and service packages to its users; design and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. Additionally, it offers NIO Certified, a used vehicle inspection, evaluation, acquisition, and sales service. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was incorporated in 2014 and is headquartered in Shanghai, China.
NYSE ended the session with Nio dropping 1.32% to $10.42 on Wednesday while NYSE rose 0.64% to $16,156.51.
Earnings Per Share
As for profitability, Nio has a trailing twelve months EPS of $-1.45.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.01%.
Volume
Today’s last reported volume for Nio is 16801900 which is 69.83% below its average volume of 55697800.
Volatility
Nio’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.87%, a positive 1.01%, and a positive 3.22%.
Nio’s highest amplitude of average volatility was 2.00% (last week), 3.57% (last month), and 3.22% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nio’s stock is considered to be overbought (>=80).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nio’s EBITDA is -3.67.
More news about Nio.
7. Deutsche Bank (DB) – Premarket: 1.08%
Deutsche Bank Aktiengesellschaft, operates as a stock corporation, engages in the provision of corporate and investment banking, and asset management products and services to private clients, corporate entities, and institutional clients worldwide. Its Corporate Bank segment provides cash management, trade finance and lending, trust and agency, foreign exchange, and securities services, as well as risk management solutions. The company's Investment Bank segment offers debt origination, merger and acquisitions, and equity advisory services. Its Private Bank segment provides payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management services, postal and parcel services; and offers support in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The company's Asset Management segment provides investment solutions, such as alternative investments, which include real estate, infrastructure, private equity, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is based in Frankfurt am Main, Germany.
NYSE ended the session with Deutsche Bank jumping 0.36% to $11.07 on Wednesday while NYSE rose 0.64% to $16,156.51.
Earnings Per Share
As for profitability, Deutsche Bank has a trailing twelve months EPS of $2.71.
PE Ratio
Deutsche Bank has a trailing twelve months price to earnings ratio of 4.08. Meaning, the purchaser of the share is investing $4.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.1%.
Volume
Today’s last reported volume for Deutsche Bank is 2181450 which is 20.53% below its average volume of 2745120.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 34.7% and a drop 5.3% for the next.
Yearly Top and Bottom Value
Deutsche Bank’s stock is valued at $11.07 at 08:34 EST, way below its 52-week high of $13.57 and way above its 52-week low of $7.25.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Deutsche Bank’s stock is considered to be oversold (<=20).
More news about Deutsche Bank.
8. NeuroMetrix (NURO) – Premarket: 1.05%
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix falling 0.2% to $0.94 on Wednesday while NASDAQ jumped 0.76% to $14,353.64.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.76%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 25.1%, now sitting on 7.68M for the twelve trailing months.
More news about NeuroMetrix.
9. DouYu (DOYU) – Premarket: 0.96%
DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors professional players and teams, and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.
NASDAQ ended the session with DouYu falling 4.17% to $1.04 on Wednesday, after three consecutive sessions in a row of losses. NASDAQ rose 0.76% to $14,353.64, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, DouYu has a trailing twelve months EPS of $0.01.
PE Ratio
DouYu has a trailing twelve months price to earnings ratio of 103.5. Meaning, the purchaser of the share is investing $103.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.17%.
More news about DouYu.
10. Tilray (TLRY) – Premarket: 0.9%
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
NASDAQ ended the session with Tilray sliding 2.07% to $1.66 on Wednesday while NASDAQ rose 0.76% to $14,353.64.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-2.85.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.15%.
Yearly Top and Bottom Value
Tilray’s stock is valued at $1.66 at 08:34 EST, way under its 52-week high of $5.12 and way above its 52-week low of $1.50.
More news about Tilray.
Premarket Losers Today
1. Advanced Semiconductor Engineering (ASX) – Premarket: -1.95%
ASE Technology Holding Co., Ltd., together with its subsidiaries, provides semiconductors packaging and testing, and electronic manufacturing services in the United States, Taiwan, Asia, Europe, and internationally. It develops, constructs, sells, leases, and manages real estate properties; produces substrates; offers information software, equipment leasing, investment advisory, and warehousing management services; processes and sells computer and communication peripherals, electronic components, telecommunications equipment, and motherboards; and imports and exports goods and technology. ASE Technology Holding Co., Ltd. was founded in 1984 and is headquartered in Kaohsiung, Taiwan.
NYSE ended the session with Advanced Semiconductor Engineering falling 0.91% to $8.19 on Wednesday, following the last session’s downward trend. NYSE rose 0.64% to $16,156.51, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Advanced Semiconductor Engineering has a trailing twelve months EPS of $0.78.
PE Ratio
Advanced Semiconductor Engineering has a trailing twelve months price to earnings ratio of 10.49. Meaning, the purchaser of the share is investing $10.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.71%.
Moving Average
Advanced Semiconductor Engineering’s worth is above its 50-day moving average of $7.89 and way above its 200-day moving average of $6.95.
Yearly Top and Bottom Value
Advanced Semiconductor Engineering’s stock is valued at $8.19 at 08:34 EST, under its 52-week high of $9.03 and way higher than its 52-week low of $4.45.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 29, 2023, the estimated forward annual dividend rate is 0.57 and the estimated forward annual dividend yield is 7.02%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 64% and a negative 19.2%, respectively.
More news about Advanced Semiconductor Engineering.
2. Banco Bradesco (BBDO) – Premarket: -1.33%
Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil.
NYSE ended the session with Banco Bradesco falling 0.34% to $3.00 on Wednesday, following the last session’s downward trend. NYSE jumped 0.64% to $16,156.51, after two successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.34.
PE Ratio
Banco Bradesco has a trailing twelve months price to earnings ratio of 8.82. Meaning, the purchaser of the share is investing $8.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.73%.
Volatility
Banco Bradesco’s last week, last month’s, and last quarter’s current intraday variation average was 0.60%, 0.24%, and 2.12%.
Banco Bradesco’s highest amplitude of average volatility was 1.10% (last week), 2.29% (last month), and 2.12% (last quarter).
More news about Banco Bradesco.
3. Canopy Growth (CGC) – Premarket: -1.31%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth jumping 3.53% to $0.39 on Wednesday, after two sequential sessions in a row of gains. NASDAQ jumped 0.76% to $14,353.64, after two consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-3.16.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.11%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 96.3% and 62.9%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canopy Growth’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for Canopy Growth is 14739500 which is 25.39% below its average volume of 19757700.
More news about Canopy Growth.
4. Manulife Financial (MFC) – Premarket: -1.24%
Manulife Financial Corporation, together with its subsidiaries, provides financial products and services in Asia, Canada, the United States, and internationally. The company operates through Wealth and Asset Management Businesses; Insurance and Annuity Products; and Corporate and Other segments. The Wealth and Asset Management Businesses segment offers investment advice and solutions to retirement, retail, and institutional clients through multiple distribution channels, including agents and brokers affiliated with the company, independent securities brokerage firms and financial advisors pension plan consultants, and banks. The Insurance and Annuity Products segment provides deposit and credit products; and individual life insurance, individual and group long-term care insurance, and guaranteed and partially guaranteed annuity products through multiple distribution channels, including insurance agents, brokers, banks, financial planners, and direct marketing. The Corporate and Other segment is involved in property and casualty reinsurance businesses; and run-off reinsurance operations, including variable annuities, and accident and health. The company also manages timberland and agricultural portfolios; and engages in insurance agency, investment counseling and dealer, portfolio and mutual fund management, property and casualty insurance, and mutual fund dealer businesses. Manulife Financial Corporation was incorporated in 1887 and is headquartered in Toronto, Canada.
NYSE ended the session with Manulife Financial jumping 0.29% to $19.28 on Wednesday while NYSE jumped 0.64% to $16,156.51.
Earnings Per Share
As for profitability, Manulife Financial has a trailing twelve months EPS of $3.83.
PE Ratio
Manulife Financial has a trailing twelve months price to earnings ratio of 5.04. Meaning, the purchaser of the share is investing $5.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.59%.
Volatility
Manulife Financial’s last week, last month’s, and last quarter’s current intraday variation average was 1.01%, 0.02%, and 1.05%.
Manulife Financial’s highest amplitude of average volatility was 1.47% (last week), 1.00% (last month), and 1.05% (last quarter).
More news about Manulife Financial.
5. HSBC (HSBC) – Premarket: -0.95%
HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions. This segment serves personal banking and high net worth individuals. The Commercial Banking segment provides credit and lending, treasury management, payment, cash management, commercial insurance, and investment services; commercial cards; international trade and receivables finance services; foreign exchange products; capital raising services on debt and equity markets; and advisory services. It serves small and medium sized enterprises, mid-market enterprises, and corporates. The Global Banking and Markets segment offers financing, advisory, and transaction services; and credit, rates, foreign exchange, equities, money markets, and securities services; and engages in principal investment activities. It serves government, corporate and institutional clients, and private investors. HSBC Holdings plc was founded in 1865 and is headquartered in London, the United Kingdom.
NYSE ended the session with HSBC rising 0.55% to $40.96 on Wednesday while NYSE jumped 0.64% to $16,156.51.
Earnings Per Share
As for profitability, HSBC has a trailing twelve months EPS of $5.6.
PE Ratio
HSBC has a trailing twelve months price to earnings ratio of 7.31. Meaning, the purchaser of the share is investing $7.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.07%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HSBC’s stock is considered to be oversold (<=20).
More news about HSBC.
6. Xenetic Biosciences (XBIO) – Premarket: -0.93%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences jumping 0.53% to $3.78 on Wednesday while NASDAQ jumped 0.76% to $14,353.64.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-3.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.06%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 55.7%, now sitting on 1.92M for the twelve trailing months.
More news about Xenetic Biosciences.
7. Prudential Public Limited Company (PUK) – Premarket: -0.82%
Prudential plc, through its subsidiaries, provides life and health insurance, and retirement and asset management solutions to individuals in Asia, and Africa. It offers health and protection, as well as non- participating savings products, such as protection and investment-linked products. The company also provides insurance against common critical illnesses; property and casualty; and tropical disease protection, such as dengue, malaria, and measles. The company was founded in 1848 and is headquartered in London, the United Kingdom.
NYSE ended the session with Prudential Public Limited Company rising 1.55% to $28.22 on Wednesday while NYSE jumped 0.64% to $16,156.51.
Earnings Per Share
As for profitability, Prudential Public Limited Company has a trailing twelve months EPS of $0.73.
PE Ratio
Prudential Public Limited Company has a trailing twelve months price to earnings ratio of 38.66. Meaning, the purchaser of the share is investing $38.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.86%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 67.8%, now sitting on -8.16B for the twelve trailing months.
More news about Prudential Public Limited Company.
8. Banco Santander (SAN) – Premarket: -0.76%
Banco Santander, S.A. provides various retail and commercial banking products and services to individuals, small and medium-sized enterprises, and large companies worldwide. The company operates through Retail Banking, Santander Corporate & Investment Banking, Wealth Management & Insurance, and PagoNxt segments. It offers demand and time deposits, and current and savings accounts; mortgages, consumer finance, syndicated corporate loans, cash management, export and agency finance, trade and working capital solutions, and corporate finance; and insurance products. The company also provides cash, asset, and wealth management; and private banking services. In addition, it is involved in the corporate banking, treasury, risk hedging, foreign trade, and investment banking activities, as well as provides digital payment solutions. The company was formerly known as Banco Santander Central Hispano S.A. and changed its name to Banco Santander, S.A. in June 2007. Banco Santander, S.A. was founded in 1856 and is headquartered in Madrid, Spain.
NYSE ended the session with Banco Santander rising 1.95% to $3.93 on Wednesday, after two consecutive sessions in a row of gains. NYSE rose 0.64% to $16,156.51, after two successive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Banco Santander has a trailing twelve months EPS of $0.61.
PE Ratio
Banco Santander has a trailing twelve months price to earnings ratio of 6.43. Meaning, the purchaser of the share is investing $6.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.82%.
Yearly Top and Bottom Value
Banco Santander’s stock is valued at $3.93 at 08:34 EST, under its 52-week high of $4.09 and way above its 52-week low of $2.26.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Santander’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 41.72B for the twelve trailing months.
More news about Banco Santander.
9. Gevo (GEVO) – Premarket: -0.6%
Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with Gevo falling 0.85% to $1.76 on Wednesday while NASDAQ jumped 0.76% to $14,353.64.
Earnings Per Share
As for profitability, Gevo has a trailing twelve months EPS of $-0.44.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.72%.
Volatility
Gevo’s last week, last month’s, and last quarter’s current intraday variation average was 0.92%, 0.97%, and 4.64%.
Gevo’s highest amplitude of average volatility was 4.93% (last week), 3.78% (last month), and 4.64% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Gevo’s stock is considered to be oversold (<=20).
Sales Growth
Gevo’s sales growth is 4394.4% for the current quarter and 227.9% for the next.
Yearly Top and Bottom Value
Gevo’s stock is valued at $1.76 at 08:34 EST, way below its 52-week high of $3.73 and way higher than its 52-week low of $1.01.
More news about Gevo.
10. Horizon Therapeutics (HZNP) – Premarket: -0.43%
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
NASDAQ ended the session with Horizon Therapeutics sliding 0% to $104.00 on Wednesday while NASDAQ rose 0.76% to $14,353.64.
Earnings Per Share
As for profitability, Horizon Therapeutics has a trailing twelve months EPS of $1.58.
PE Ratio
Horizon Therapeutics has a trailing twelve months price to earnings ratio of 65.83. Meaning, the purchaser of the share is investing $65.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.5%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Horizon Therapeutics’s EBITDA is 194.01.
More news about Horizon Therapeutics.
Stay up to date with our premarket winners and losers daily report
